©2011 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Aug 6, 2011; 2(4): 27-35
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Table 4 Assessment of stress ulcer prophylaxis practice
| SUP variable | n (%) |
| Indication | |
| Non-Candidates for SUP1 | 673 (67) |
| Candidates for SUP2 | 331 (33) |
| 1 major risk factor3 | 53 (25.2) |
| 2 minor risk factors4 | 204 (20.3) |
| 7 d stay in ICU and 1 minor risk factor | 38 (3.8) |
| Dose | |
| Appropriate | 891 (88.9) |
| Inappropriate | 111 (11.1) |
| Route | |
| Oral | 232 (23.2) |
| Parenteral | 770 (76.8) |
| Inappropriate5 | 551 (71.6) |
| Duration (d) | |
| Median (IQR) | 4.0 (5)6 |
| Regimen (dose + route + duration) | |
| Appropriate | 124 (12.4) |
| Inappropriate | 880 (87.6) |
- Citation: Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther 2011; 2(4): 27-35
- URL: https://www.wjgnet.com/2150-5349/full/v2/i4/27.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v2.i4.27